|
|
Legal status
Patent not validated
| (51) | INT.CL. | G01N 33/50 | (2006.01) |
| C12Q 1/48 | (2006.01) | ||
| C12R 1/19 | (2006.01) | ||
| G01N 33/15 | (2006.01) | ||
| G01N 33/566 | (2006.01) | ||
| G01N 33/60 | (2006.01) | ||
| G01N 33/68 | (2006.01) |
| (11) | Number of the document | 1171631 |
| (13) | Kind of document | T |
| (96) | European patent application number | 00925833.6 |
| Date of filing the European patent application | 2000-04-19 | |
| (97) | Date of publication of the European application | 2002-01-16 |
| (45) | Date of publication and mention of the grant of the patent | 2004-10-13 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/SE2000/0007 |
| Date | 2000-04-19 |
| (87) | Number | WO 2000/065087 |
| Date | 2000-11-02 |
| (30) | Number | Date | Country code |
| PCT/IN99/00013 | 1999-04-22 | WO |
| (72) |
DAS, Kaveri, AstraZeneca R & D Bangalore, IN
RAMACHANDRAN, Janakiraman, AstraZeneca, IN
|
| (73) |
AstraZeneca AB,
151 85 Södertälje,
SE
|
| (54) | ASSAY FOR DETECTING PHOSPHO-N-ACETYLMURAMYL-PENTAPEPTIDE TRANSLOCASE ACTIVITY |
| ASSAY FOR DETECTING PHOSPHO-N-ACETYLMURAMYL-PENTAPEPTIDE TRANSLOCASE ACTIVITY |